{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Fort Worth",
      "state": "TX",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74209",
      "recalling_firm": "Galderma Laboratories, L.P.",
      "address_1": "14501 N Freeway Tx",
      "address_2": "",
      "postal_code": "76177",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-1031-2016",
      "product_description": "Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only.  Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30.",
      "product_quantity": "71,340 Bottles",
      "reason_for_recall": "Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.",
      "recall_initiation_date": "20160519",
      "center_classification_date": "20160614",
      "termination_date": "20161223",
      "report_date": "20160622",
      "code_info": "Lot #: 1496059A, Expiry: 08/31/2017; Lot #: AD9848A, Expiry: 11/30/2017",
      "more_code_info": ""
    }
  ]
}